Seguir
M.C.F. Cysouw
M.C.F. Cysouw
Postdoctoral researcher, Radiology and Nuclear Medicine, Amsterdam UMC
Dirección de correo verificada de amsterdamumc.nl
Título
Citado por
Citado por
Año
Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
MCF Cysouw, BHE Jansen, T van de Brug, DE Oprea-Lager, E Pfaehler, ...
European journal of nuclear medicine and molecular imaging 48, 340-349, 2021
1082021
Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis
MCF Cysouw, GM Kramer, LJ Schoonmade, R Boellaard, HCW de Vet, ...
European journal of nuclear medicine and molecular imaging 44, 2105-2116, 2017
522017
Simplified methods for quantification of 18F-DCFPyL uptake in patients with prostate cancer
BHE Jansen, M Yaqub, J Voortman, MCF Cysouw, AD Windhorst, ...
Journal of nuclear medicine 60 (12), 1730-1735, 2019
452019
Benefits of using stereotactic body radiotherapy in patients with metachronous oligometastases of hormone-sensitive prostate cancer detected by [18F] fluoromethylcholine PET/CT
EW Bouman-Wammes, JM van Dodewaard-De Jong, M Dahele, ...
Clinical genitourinary cancer 15 (5), e773-e782, 2017
442017
Repeatability of quantitative 18F-DCFPyL PET/CT measurements in metastatic prostate cancer
BHE Jansen, MCF Cysouw, AN Vis, RJA van Moorselaar, J Voortman, ...
Journal of Nuclear Medicine 61 (9), 1320-1325, 2020
332020
Healthy tissue uptake of 68Ga-prostate-specific membrane antigen, 18F-DCFPyL, 18F-fluoromethylcholine, and 18F-dihydrotestosterone
BHE Jansen, GM Kramer, MCF Cysouw, MM Yaqub, B de Keizer, ...
Journal of Nuclear Medicine 60 (8), 1111-1117, 2019
332019
Accuracy and precision of partial-volume correction in oncological PET/CT studies
MCF Cysouw, GM Kramer, OS Hoekstra, V Frings, AJ de Langen, EF Smit, ...
Journal of Nuclear Medicine 57 (10), 1642-1649, 2016
332016
Targeting PSMA revolutionizes the role of nuclear medicine in diagnosis and treatment of prostate cancer
WI Luining, MCF Cysouw, D Meijer, NH Hendrikse, R Boellaard, AN Vis, ...
Cancers 14 (5), 1169, 2022
272022
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
JJ Eertink, GJC Zwezerijnen, MCF Cysouw, SE Wiegers, EAG Pfaehler, ...
European journal of nuclear medicine and molecular imaging 49 (13), 4642-4651, 2022
242022
Bone metastases are measurable: the role of whole-body MRI and positron emission tomography
DE Oprea-Lager, MCF Cysouw, R Boellaard, CM Deroose, ...
Frontiers in oncology 11, 772530, 2021
232021
Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
MCF Cysouw, SVS Golla, V Frings, EF Smit, OS Hoekstra, GM Kramer, ...
EJNMMI research 9, 1-11, 2019
232019
Classification of negative and positive 18F-florbetapir brain PET studies in subjective cognitive decline patients using a convolutional neural network
BM de Vries, SSV Golla, J Ebenau, SCJ Verfaillie, T Timmers, F Heeman, ...
European Journal of Nuclear Medicine and Molecular Imaging 48, 721-728, 2021
182021
Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
MCF Cysouw, GM Kramer, D Heijtel, RC Schuit, MJ Morris, ...
EJNMMI research 9, 1-12, 2019
132019
Prognostic value of [18F]-fluoromethylcholine positron emission tomography/computed tomography before stereotactic body radiation therapy for oligometastatic prostate cancer
M Cysouw, E Bouman-Wammes, O Hoekstra, A van den Eertwegh, M Piet, ...
International Journal of Radiation Oncology* Biology* Physics 101 (2), 406-410, 2018
132018
Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake
MCF Cysouw, BHE Jansen, M Yaqub, J Voortman, AN Vis, ...
Molecular Imaging and Biology 22, 15-17, 2020
112020
Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images
MCF Cysouw, GM Kramer, V Frings, AJ De Langen, MJ Wondergem, ...
Nuclear medicine and biology 51, 18-24, 2017
72017
Reply: Quantification of 18F-DCFPyL uptake: TBR versus Patlak’s analysis
BHE Jansen, M Yaqub, MCF Cysouw, AN Vis, RJA van Moorselaar, ...
Journal of Nuclear Medicine 60 (12), 1834-1835, 2019
32019
SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
YJL Bodar, BPF Koene, BHE Jansen, MCF Cysouw, D Meijer, ...
Journal of Nuclear Medicine 62 (9), 1264-1269, 2021
22021
A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients …
WI Luining, LMS Boevé, MJ Hagens, D Meijer, T de Weijer, RH Ettema, ...
European Urology Oncology, 2024
2024
The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach
CFM van Hooijdonk, M van der Pluijm, BM de Vries, M Cysouw, ...
Schizophrenia Research 262, 132-141, 2023
2023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20